Article
Decreased p66Shc promoter methylation in patients with end-stage renal disease
1 Jan 2007
Abstract excerpt
BACKGROUND: p66Shc is a stress response protein and partially regulated by epigenetic modifications. Mice lacking p66Shc have reduced atherosclerosis, increased resistance to oxidative stress and a prolonged life time. The aim of the present study was to compare promoter methylation of the p66Shc gene between healthy controls and patients with end-stage renal disease (ESRD). There are two reasons for studying...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
